TAMPA, Fla. — Indian drugmaker Aurobindo Pharma, U.S. drugmakers Sciegen Pharmaceuticals and Westminster Pharmaceuticals, and retailer Walmart distributed and sold irbesartan, a medicine for high blood pressure, contaminated with carcinogenic N-nitrosodiethylamine, consumers claim in a federal class action.
Subscribe to our free newsletters
Our weekly newsletter Closing Arguments offers the latest about ongoing trials, major litigation and rulings in courthouses around the U.S. and the world, while the monthly Under the Lights dishes the legal dirt from Hollywood, sports, Big Tech and the arts.

